3Commas
3Commas equips crypto traders with innovative tools designed to simplify trading workflows, reduce risks, and support the pursuit of optimized strategies—all within a secure, all-in-one platform.
Advanced Bots: Tailor automated trading to match your strategy, leveraging DCA, Signal, and Grid bots for various market scenarios.
Unified Dashboard: Effortlessly connect and manage accounts across 15 leading exchanges.
Smart Trade: Take advantage of tools like Trailing Take Profit, Multiple Take Profit, and Trailing Stop Loss for precise trade execution.
Mobile & API Access: Access your trading tools anytime through free mobile apps and public APIs for added convenience.
Paper Trading: Refine your strategies risk-free using virtual assets.
Relied on by traders globally, 3Commas delivers cutting-edge solutions for smarter and more efficient trading.
Learn more
LeanData
LeanData’s no-code Go-to-Market Execution platform helps leading B2B companies drive smarter decisions and stronger revenue outcomes. By unifying data, tools, and teams, LeanData empowers organizations like Nvidia, Cisco, and Palo Alto Networks to streamline operations, accelerate pipeline, and improve customer engagement from first signal to closed-won.
Learn more
CoVigilAI
CoVigilAI is a cutting-edge solution for monitoring medical literature that leverages artificial intelligence and sophisticated data analysis to identify and manage adverse drug reactions proactively, thereby safeguarding patient well-being and adhering to regulatory standards in real time. This platform simplifies the tracking of scientific and medical literature by sourcing information from major global databases like PubMed and Embase, offering customizable search parameters that enhance the pharmacovigilance literature review process. Additionally, it systematically reviews scientific articles and publications from various local journals, ensuring comprehensive global and localized literature oversight. Utilizing advanced algorithms, the system classifies Individual Case Safety Reports (ICSRs) into three categories: valid, potential, and invalid cases, while its automated key entity recognition capability adeptly identifies essential elements such as patients, medications, adverse reactions, and relevant medical events. This holistic approach not only streamlines the monitoring process but also significantly enhances the accuracy and efficiency of drug safety assessments.
Learn more
IQVIA
Numerous organizations globally rely on IQVIA to accelerate the drug development process, guarantee the safety and quality of products, enhance commercial efficacy, deliver appropriate treatments to patients, and ultimately promote improved health outcomes by facilitating access to and delivery of healthcare. Transform your approach to clinical development by seamlessly integrating data, technology, and analytics to streamline your trials. The outcome? Quicker decision-making and minimized risks, enabling you to provide transformative therapies at a faster pace. With its expertise rooted in data, sophisticated analytics, and deep industry knowledge, IQVIA offers tailored capabilities to clients throughout the healthcare landscape. Stay informed by exploring the latest insights and updates from IQVIA's data scientists, healthcare professionals, researchers, and other industry experts on crucial topics that resonate with your interests. From emerging industry developments to practical applications of our capabilities, a wealth of information awaits you here. Engaging with this content also empowers you to stay ahead in a rapidly evolving healthcare environment.
Learn more